Breast Satisfaction Increased for Women Undergoing Autologous Reconstruction
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 17, 2023 -- Women undergoing autologous breast reconstruction have higher levels of breast satisfaction and psychosocial and sexual well-being at six weeks and six months after reconstruction compared with those undergoing alloplastic breast reconstruction, according to a study published online in the October issue of Plastic and Reconstructive Surgery.
Nadia Sadok, M.D., Ph.D., from the University of Groningen in the Netherlands, and colleagues measured changes in quality of life after breast reconstruction in a prospective multicenter study using the BREAST-Q questionnaire, which was administered preoperatively and at six weeks and six months postoperatively. Characteristics and complications were compared for those undergoing autologous and alloplastic breast reconstruction.
The researchers found that compared with women undergoing alloplastic breast reconstruction, women undergoing autologous breast reconstruction scored lower on all BREAST-Q scales, regardless of whether they underwent immediate or delayed breast reconstruction. Significantly higher scores on the Satisfaction with Breasts, Psychosocial Well-Being, and Sexual Well-Being subscales were seen at six weeks and six months postoperatively for women undergoing autologous breast reconstruction. The groups had similar scores on the postoperative Physical Well-Being: Chest subscale. Women in the autologous group more often had Clavien-Dindo grade III or higher complications (27 versus 12 percent). There was no association seen between complications and worse BREAST-Q scores on any of the subscales.
"The findings were unexpected, since autologous breast reconstruction is a more complex procedure, with a higher rate of severe complications," Sadok said in a statement.
One author disclosed ties to Fidia Ltd.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...
Few Patients With Positive Margins After Basal Cell Excision Have Recurrence
MONDAY, July 1, 2024 -- Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence...
NCCN: Cancer Drug Shortages Remain a Challenge for Clinicians
FRIDAY, June 28, 2024 -- Almost 90 percent of medical centers report cancer drug shortages, which often impact clinical trials, according to the results of a National...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.